🇺🇸 UTHR — United Therapeutics Corporation
Salud CompraPrecio actual
601,32 USD
Máx. histórico
601,32
0 días
Split 2:1 del 23/09/2009
Caída desde máximo
En máximo
Rango 52 semanas
430,02 – 609,99
Variación hoy
+0,87%
Cierre anterior
596,13
Rango de hoy
596,14 – 606,16
Volumen hoy
595.233
Peor caída histórica
-93,18%
12/07/2000 → 10/12/2001
Recuperado en 3311 días
Volatilidad anualizada ⓘ
46,95%
- Nombre completo
- United Therapeutics Corporation
- Divisa
- USD
- Mercado
- NasdaqGS
- Sector
- Salud
- Industria
- Drug Manufacturers - Specialty & Generic
- Empleados
- 1.400
- PER ⓘ
- 21,54 (puede no estar actualizado)
- Dividend yield
- 0,00% (puede no estar actualizado)
- Precio objetivo analistas
- 670,93 USD (puede no estar actualizado)
- Primera cotización
- 17/06/1999
- Precio actualizado
- hace 9 horas
United Therapeutics Corporation engages in the development and commercialization of products to address the unmet medical needs of patients with chronic and life-threatening diseases in the United States and internationally. It offers Tyvaso DPI, an inhaled dry powder via pre-filled and single-use cartridges; Nebulized Tyvaso, an inhaled solution via ultrasonic nebulizer; Remodulin (treprostinil) injection to treat patients with pulmonary arterial hypertension to diminish symptoms associated with exercise; Orenitram, a tablet dosage form of treprostinil, to delay disease progression and improve exercise capacity in PAH patients; and Adcirca, an oral PDE-5 inhibitor to enhance the exercise ability in PAH patients. It also markets and sells Unituxin (dinutuximab) injection, a monoclonal antibody for high-risk neuroblastoma; and Remunity Pump, which contains a pump and separate controller for Remodulin. In addition, it is involved in developing RemunityPRO Pump and Ralinepag for the treatment of PAH;and Nebulized Tyvaso, for the treatment of idiopathic pulmonary fibrosis, as well as xenografts, which are development-stage organ products. Further, it provides preclinical products, including EVLP/CLES, for lung transplant; UKidney, UHeart, UThymoKidney, a development-stage gene-edited porcine kidneys and hearts for xenotransplantation; ULobe, for allogeneic regenerative medicine; ULung, for autologous regenerative medicine; IVIVA Kidney, for autologous regenerative medicine; miroliver, for allogeneic regenerative medicine; and mirokidney, for allogeneic regenerative medicine. It has licensing and collaboration agreements with DEKA Research & Development Corp. to develop a semi-disposable system for the subcutaneous delivery of treprostinil; MannKind Corporation to develop and license treprostinil inhalation powder and the Dreamboat device; and Arena Pharmaceuticals, Inc. to develop Ralinepag. The company was founded in 1996 and is headquartered in Silver Spring, Maryland.
| Fecha | Ratio |
|---|---|
| 23/09/2009 | 2:1 |
| Fecha | Apertura | Máximo | Mínimo | Cierre | Variación | Volatilidad día | Volumen |
|---|---|---|---|---|---|---|---|
| 26/01/2001 | 7,97 | 7,97 | 7,50 | 7,63 | -2,40% | 5,88% | 169.600 |
| 25/01/2001 | 8,56 | 8,63 | 7,63 | 7,81 | -6,02% | 11,68% | 247.400 |
| 24/01/2001 | 7,81 | 8,63 | 7,81 | 8,31 | +7,26% | 10,40% | 347.000 |
| 23/01/2001 | 7,83 | 7,91 | 7,69 | 7,75 | -1,20% | 2,80% | 275.200 |
| 22/01/2001 | 7,49 | 7,88 | 7,25 | 7,84 | +5,91% | 8,34% | 145.800 |
| 19/01/2001 | 7,56 | 7,56 | 7,34 | 7,41 | +0,00% | 2,89% | 162.200 |
| 18/01/2001 | 7,49 | 7,50 | 7,06 | 7,41 | +1,28% | 5,84% | 284.600 |
| 17/01/2001 | 8,13 | 8,31 | 7,16 | 7,31 | +0,43% | 14,23% | 604.000 |
| 16/01/2001 | 6,45 | 7,50 | 6,44 | 7,28 | +13,66% | 16,48% | 1.028.600 |
| 12/01/2001 | 6,08 | 6,49 | 6,03 | 6,41 | +6,77% | 7,58% | 898.600 |
| 11/01/2001 | 5,75 | 6,50 | 5,72 | 6,00 | +6,08% | 13,59% | 986.200 |
| 10/01/2001 | 5,75 | 5,84 | 5,63 | 5,66 | +0,00% | 3,81% | 578.400 |
| 09/01/2001 | 5,75 | 5,75 | 5,56 | 5,66 | +0,00% | 3,26% | 738.200 |
| 08/01/2001 | 6,31 | 6,38 | 5,56 | 5,66 | -5,73% | 12,87% | 556.400 |
| 05/01/2001 | 6,34 | 6,38 | 6,00 | 6,00 | -2,04% | 5,91% | 1.253.000 |
| 04/01/2001 | 6,94 | 6,94 | 6,00 | 6,13 | -6,22% | 13,51% | 208.600 |
| 03/01/2001 | 6,94 | 7,02 | 5,88 | 6,53 | -7,52% | 16,44% | 638.400 |
| 02/01/2001 | 7,67 | 7,72 | 7,03 | 7,06 | -4,24% | 8,96% | 363.400 |
| 29/12/2000 | 7,13 | 7,81 | 6,94 | 7,38 | +6,31% | 12,28% | 732.000 |
| 28/12/2000 | 6,52 | 6,94 | 6,50 | 6,94 | +6,22% | 6,71% | 1.256.200 |
| 27/12/2000 | 6,95 | 6,97 | 6,50 | 6,53 | -2,34% | 6,74% | 1.182.800 |
| 26/12/2000 | 7,03 | 7,03 | 6,38 | 6,69 | -3,60% | 9,33% | 950.400 |
| 22/12/2000 | 6,88 | 7,06 | 6,75 | 6,94 | +2,30% | 4,55% | 174.000 |
| 21/12/2000 | 7,13 | 7,13 | 6,72 | 6,78 | -3,12% | 5,70% | 425.400 |
| 20/12/2000 | 6,74 | 7,03 | 6,50 | 7,00 | +0,45% | 7,88% | 651.600 |
| 19/12/2000 | 7,44 | 7,50 | 6,88 | 6,97 | -5,51% | 8,40% | 429.400 |
| 18/12/2000 | 7,97 | 8,06 | 7,31 | 7,38 | -5,98% | 9,41% | 664.400 |
| 15/12/2000 | 7,77 | 8,06 | 7,31 | 7,84 | +8,31% | 9,66% | 250.800 |
| 14/12/2000 | 8,10 | 8,16 | 7,19 | 7,24 | -10,52% | 11,96% | 1.075.200 |
| 13/12/2000 | 8,30 | 8,31 | 8,06 | 8,09 | +1,17% | 3,01% | 1.108.400 |